Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Greater optimism regarding recovery from chronic illness is associated with improved quality of life and clinical outcomes. We performed a post-hoc analysis on the association between optimism and outcomes in Ranolazine in Patients with Incomplete Revascularization after Percutaneous Coronary Intervention (RIVER-PCI), a randomized trial in patients with chronic angina pectoris who had incomplete revascularization following percutaneous coronary intervention. At baseline, patients answered how much they agreed with the phrase, "I am optimistic about my future and returning to a normal lifestyle." We evaluated the association between baseline optimism and time to ischemia-driven hospitalization or revascularization using a Cox model, and the association between baseline optimism and change in frequency of angina pectoris using a mixed measures model. Of 2,389 patients, 782 (33.2%) were very optimistic ("strongly agree"), 1,000 (42.4%) were optimistic ("agree"), 451 (19.1%) were neutral ("undecided"), and 123 (5.2%) were not optimistic ("disagree" or "strongly disagree"). Very optimistic patients had a lower prevalence of co-morbidities and less severe angina at baseline than less optimistic patients. The rate of ischemia-driven revascularization or hospitalization was higher in neutral and not optimistic patients compared with very optimistic patients; this finding persisted after adjustment for co-morbidities and baseline angina frequency (hazard ratio 1.42, 95% confidence interval 1.14 to 1.77 for neutral vs very optimistic; hazard ratio 1.38, 95% confidence interval 0.98 to 1.94 for not optimistic vs very optimistic). Neutral and not optimistic patients also had less improvement in angina than very optimistic patients. In conclusion, in patients with angina, those with more self-reported optimism had better health status outcomes. Whether structured interventions targeting optimism improve outcomes in these patients warrants further study.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064151 | PMC |
| http://dx.doi.org/10.1016/j.amjcard.2019.01.036 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Therapeutic Potential of Agmatine in Alcohol Use Disorder: Preclinical insights and future directions.
Behav Brain Res
September 2025
Department of Pharmacology, Smt. Kishoritai Bhoyar College of Pharmacy, New Kamptee, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, MS 441 002, India. Electronic address:
Alcohol Use Disorder (AUD) is a major global health challenge characterized by the recurrence of alcohol consumption, withdrawal symptoms, and significant social, economic, and health-related burdens. Despite conventional treatments such as cognitive behavioral therapy and medications like disulfiram and naltrexone, the majority of patients do not achieve adequate relief due to the multifactorial nature of this disorder, including mental health issues and neuroadaptive changes. Recent studies demonstrated that chronic alcohol consumption results in the disruption of both the production and signaling of endogenous agmatine, a neuromodulator synthesized from L-arginine.
View Article and Find Full Text PDFClinical apathy might result from either a diminished willingness to exert effort for known rewards or from reduced motivation to explore potentially beneficial future opportunities. To identify the underlying cognitive and neural bases of apathy, we used task-based fMRI to examine motivated choice computations in patients with chronic traumatic brain injury (TBI)-a condition frequently associated with apathy-and compared their behavior and neural activity to that of healthy controls (CTRLs). Participants performed two choice tasks involving distinct types of motivational tradeoffs: i) An effort-value tradeoff task (the 'Apples Task') requiring them to decide how much physical effort they were willing to exert for varying reward magnitudes, and ii) An explore-exploit tradeoff task (the 'Novelty-Bandit Task') requiring them to choose between exploiting options with a known history of reward or exploring novel options with uncertain but potentially higher future value.
View Article and Find Full Text PDFThe current report on drug development focuses on "The new dimension" of cancer hallmarks.
Gene
September 2025
Laboratory of Macromolecular Engineering, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada Sekip Utara II, 55281 Yogyakarta, Indonesia; Laboratory of Advanced Pharmaceutical Sciences. APSLC Building, Faculty of Pharmacy, Universitas Gadjah Mada Sekip Utara II, 552
Cancer remains a significant global challenge, affecting millions, but progress has been made in understanding its development and advancement. The discovery of cancer drugs focuses on identifying "new dimension" hallmarks of cancer, such as phenotypic plasticity, senescence, polymorphic microbiota, and non-mutational epigenetic reprogramming. These elements are crucial in tumor development and treatment.
View Article and Find Full Text PDFFLASH-enabled Proton SBRT for a challenging case of spine metastasis.
Phys Med Biol
September 2025
Department of oncology, Laboratory of Experimental Radiotherapy, KU Leuven, Herestraat 49, Leuven, Vlaanderen, 3001, BELGIUM.
Objective: The FLASH effect, characterized by potential sparing of organs at risk (OAR) through ultra-high dose rate irradiation, has garnered significant attention for its capability to address indications previously untreatable at conventional dose rates (DR) with hypofractionated schemes. While considerable biological research is needed to understand the FLASH effect and determine the FLASH modifying factors (FMF) for individual OARs, treatment planning studies have also emerged. This study evaluates the feasibility of achieving FLASH conditions in proton stereotactic body radiotherapy for spine metastases and establishes the required FMFs under different fractionation regimens.
View Article and Find Full Text PDFTexas Health Care Workers Respond to Climate Change.
Public Health Nurs
August 2025
Texas Health Resources, Fort Worth, Texas, USA.
Objective: The purpose of this study was to measure healthcare worker awareness of climate change and concern about its impact on health.
Design: Cross-sectional population study.
Sample: Researchers administered the CHANT Tool to a convenience sample of 691 employees of a large health system in North Texas ranging from 20 to 75 years of age.